PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer
Clinical trial NCT03166085 · COMPLETED
Trial details
- NCT number
- NCT03166085
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-23
- Primary completion
- 2021-12-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.